| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Cox Christopher K | Chief Product Officer | C/O META PLATFORMS, INC., 1 META WAY, MENLO PARK | /s/ Erin Guldiken, attorney-in-fact for Christopher K. Cox | 08 Aug 2025 | 0001607459 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | META | Class A Common Stock | Sale | -$1.73M | -2.27K | -0.96% | $764.74 | 235K | 06 Aug 2025 | Christopher K. Cox Revocable Trust | F1, F2, F3 |
| transaction | META | Class A Common Stock | Sale | -$752K | -983 | -0.42% | $765.43 | 234K | 06 Aug 2025 | Christopher K. Cox Revocable Trust | F1, F3, F4 |
| transaction | META | Class A Common Stock | Sale | -$1.88M | -2.45K | -1.05% | $766.77 | 232K | 06 Aug 2025 | Christopher K. Cox Revocable Trust | F1, F3, F5 |
| transaction | META | Class A Common Stock | Sale | -$1.09M | -1.42K | -0.61% | $768.07 | 230K | 06 Aug 2025 | Christopher K. Cox Revocable Trust | F1, F3, F6 |
| transaction | META | Class A Common Stock | Sale | -$4.55M | -5.92K | -2.57% | $768.99 | 224K | 06 Aug 2025 | Christopher K. Cox Revocable Trust | F1, F3, F7 |
| transaction | META | Class A Common Stock | Sale | -$1.2M | -1.56K | -0.7% | $769.86 | 223K | 06 Aug 2025 | Christopher K. Cox Revocable Trust | F1, F3, F8 |
| transaction | META | Class A Common Stock | Sale | -$307K | -398 | -0.18% | $770.76 | 222K | 06 Aug 2025 | Christopher K. Cox Revocable Trust | F1, F3, F9 |
| holding | META | Class A Common Stock | 55K | 06 Aug 2025 | Cox-Vadakan Irrevocable Remainder Trust | F10 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The sales reported were effected pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on May 5, 2025. |
| F2 | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $764.235 to $765.195 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F3 | Shares held of record by Christopher K. Cox, Trustee of The Christopher K. Cox Revocable Trust. |
| F4 | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $765.25 to $766.055 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F5 | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $766.31 to $767.13 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F6 | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $767.50 to $768.49 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F7 | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $768.50 to $769.44 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F8 | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $769.505 to $770.14 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F9 | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $770.58 to $770.88 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F10 | Shares held of record by Christopher K. Cox and Visra Vichit-Vadakan, Co-Trustees of The Cox-Vadakan Irrevocable Remainder Trust. |